Cimeio
is a Switzerland-based biotechnology company that develops and commercializes cell therapies for the treatment of genetic and autoimmune disorders... Read moreCimeio
is a Switzerland-based biotechnology company that develops and commercializes cell therapies for the treatment of genetic and autoimmune disorders... Read more
News
Dec 16, 2024
Global Legal Chronicle
Cimeio: Cimeio Therapeutics' Partnership with Kyowa Kirin
Dec 12, 2024
Startupticker
Cimeio: Cimeio signs $300 million agreement with Japanese pharma company
May 22, 2024
FinanzNachrichten
Cimeio: Cimeio Therapeutics Announces Publication in Nature Demonstrating That CD45 ADC and Shielded HSCs Represent a Potentially Universal Therapy for Blood Cancers
May 09, 2024
FinanzNachrichten
Cimeio: Cimeio Therapeutics Presents Data for its CD52 Shielding Variant at ASGCT
Dec 12, 2023
FinanzNachrichten
Cimeio: Cimeio Therapeutics Presents Data for its CD45 Universal Heme ADC at ASH
Nov 03, 2023
FinanzNachrichten
Cimeio: Cimeio Therapeutics Announces Poster Presentations at ASH 2023
Oct 16, 2023
Yahoo
Cimeio: Cimeio Therapeutics Announces Research Collaboration With the University of Pennsylvania to Conduct Preclinical Studies of a CD45 Universal CAR T Cell Therapy for Patients With Blood and Bone Marrow Cancers
Sep 29, 2023
FinanzNachrichten
Cimeio: Cimeio Therapeutics Announces Publication of Seminal Epitope Editing Work in the Journal of Experimental Medicine
Jun 22, 2023
Yahoo
Cimeio: Prime Medicine and Cimeio Therapeutics Announce Research Collaboration to Develop Prime Edited Shielded-Cell & Immunotherapy Pairs for Genetic Diseases, Acute Myeloid Leukemia and Myelodysplastic Syndrome
May 16, 2023
FinanzNachrichten
Cimeio: Cimeio Therapeutics Presents Additional Proof-of-Concept Data for SCIP Platform
